Oxford Expression Technologies launches US hub

San Diego, CA, USA – Oxford Expression Technologies (OET), the award-winning specialist provider of recombinant protein expression solutions, has opened a new US hub site. The inauguration of this new hub, which is operated by San Diego based biotech company Abcore Inc, will not only allow customers in the United States to purchase OET products from a North American supplier, but will also give them access to the complete range of OET’s world-renowned recombinant protein expression expertise and services, including:

proteinXPRESS, a high-quality, tailor-made and comprehensive recombinant protein expression service (from gene synthesis to protein expression/purification), including vaccine and Virus like Particle (VLP) production

flashBAC baculovirus expression kits, genetically optimized for producing 100% recombinant virus in a single step by eliminating the need for plaque purification, together with enhanced recombinant protein yield and quality to deliver unbeatable value.

Baculovirus expression training courses and individually tailored training in baculovirus expression technology.

“We are absolutely delighted with the alliance with AbCore,” commented James Bernard, CEO, OET. “AbCore is more than just a distributor – they will become our North American hub, operating from AbCore’s facilities in the heart of Southern California’s biotech cluster. AbCore will ensure that customers across North America will have access to our recombinant protein expression offerings. Orders will be accomplished in real-time without the hassle of shipping into the US and payment will be made in local currency.”

“We will offer the full range of OET products, from stock. This means that logistical issues around importing materials into North America will be completely eliminated. Additionally, all customers will receive their orders within 48 hours of it being placed, and can use a dedicated US-based toll free number (+1 866-796-2330) across all time zones for immediate assistance,” said Steven Evans, President, AbCore.

< | >